The aim of this study is to conduct a hybrid effectiveness/implementation assessment of the International Guide for Monitoring Child Development (GMCD) in two LMIC settings, India and Guatemala, within established rural CHW programs. The primary objectives are (a) to evaluate the real-world effectiveness of the GMCD; (b) to use an implementation science framework to understand barriers and facilitators to effective population coverage, provider implementation, and maintenance; (c) to conduct an economic evaluation of the GMCD.
Specific Aim 1: Assess the effectiveness of the GMCD intervention to improve developmental outcomes and nurturing care in India and Guatemala. The investigators will conduct a parallel-arm cluster randomized trial within rural CHW programs. In the primary effectiveness phase, children under 2 years old will receive the GMCD intervention or control for 12 months. Subsequently, control clusters will cross into the intervention, and continue an additional 12 months (total 24 study months). The primary developmental effectiveness outcome will be change in age-adjusted scores at 12 months on the Bayley Scales of Infant Development, 4th Edition BSID4) (3). The secondary nurturing care effectiveness outcome will be change in mean Home Observation for Measurement of the Environment (HOME) score at 12 months (4). Specific Aim 2: Assess barriers and facilitators to GMCD implementation using the RE-AIM evaluation framework (5). RE-AIM domains will be assessed as: (a) Reach: participation rates, comparison of participant/non-participant characteristics, attendance/drop-out; (b) Effectiveness: impact on development (BSID4) and nurturing environment (HOME) \[in Aim 1\]; (c) Adoption: proportion of workers/facilities participating, CHW characteristics; (d) Implementation: contact hours/visit completion, fidelity to delivery protocols; (e) Maintenance: patient outcomes and cost effectiveness analysis at 12-24 months \[in Aim 3\]; intent by decision makers and implementers to continue intervention. In addition, the investigators will conduct a sequential quantitative--\>qualitative explanatory analysis, using interviews and focus groups with implementers from clusters with highest/lowest impact outcomes (BSID4/HOME) to explore institutional inner and outer setting and implementation processes associated with intervention success, using the Consolidated Framework for Implementation Research (CFIR). Specific Aim 3: Conduct an economic evaluation of the GMCD intervention. Evaluation will assess (a) costs of the interventions at 12 and 24 months; and (b) cost-effectiveness of the intervention (dollar per unit increase in BSID or HOME scores) at 12 months. This analysis will provide cost information to policymakers to help guide resource allocation decisions for ECD interventions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
624
Monthly GMCD visits includes assessment of risk factors, open-ended exploration of caregiver concerns about development, assessment of functioning in seven developmental domains, and using mutual problem solving strategies to develop a nurturing care plan with the caregiver.
Wuqu' Kawoq
Tecpán Guatemala, Guatemala
Mahatma Gandhi Institute of Medical Sciences
Sevāgrām, Maharashtra, India
Change in Composite Language Score at 12 months
Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 47-153
Time frame: Change from 0 to 12 months
Change in Composite Motor Score at 12 months
Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 46-154
Time frame: Change from 0 to 12 months
Change in Composite Cognitive Score at 12 months
Using the Bayley Scales of Infant Development, 4th Edition (BSID4), higher scores better, scale range 55-145
Time frame: Change from 0 to 12 months
Change in the Home Observation for Measurement of the Environment Scale (HOME) Raw Score
Raw score range 0-45, higher scores better
Time frame: Change from 0 to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.